HCPCS drug code · CMS crosswalk
Bupivacaine HCl J-Code / HCPCS Code
In short
Bupivacaine HCl is billed under HCPCS J0665 — Injection, bupivicaine, not otherwise specified, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 61 Bupivacaine HCl NDCs under this code.
Reference
- J0665
- Injection, bupivicaine, not otherwise specified, 0.5 mgBilling unit: 0.5 mg
- Labelers
- A-S Medication Solutions; Brookfield Pharmaceuticals, LLC; Eugia US LLC; Fosun Pharma Usa Inc.; HF Acquisition Co. LLC, DBA HealthFirst; Henry Schein Inc.; Hikma Pharmaceuticals USA Inc.; Meitheal Pharmaceuticals Inc.and 4 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Bupivacaine HCl units and claim line
Enter the dose given to get the J0665 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Bupivacaine HCl NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9328-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 50 | 2500 |
| 00143-9329-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 50 | 5000 |
| 00143-9330-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 500 |
| 00143-9331-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 1000 |
| 00143-9332-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 1500 |
| 00143-9333-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 30 | 1500 |
| 00143-9334-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 30 | 3000 |
| 00143-9335-10 | J0665 | Hikma Pharmaceuticals USA Inc. | 10 × 30 | 4500 |
| 00404-9826-50 | J0665 | Henry Schein Inc. | 50 | 250 |
| 00404-9827-50 | J0665 | Henry Schein Inc. | 50 | 500 |
| 00409-1159-01 | J0665 | Pfizer Inc | 25 × 10 | 1250 |
| 00409-1159-02 | J0665 | Pfizer Inc | 25 × 30 | 3750 |
| 00409-1159-10 | J0665 | Pfizer Inc | 25 × 30 | 3750 |
| 00409-1160-01 | J0665 | Pfizer Inc | 25 × 50 | 6250 |
| 00409-1162-01 | J0665 | Pfizer Inc | 25 × 10 | 2500 |
| 00409-1162-02 | J0665 | Pfizer Inc | 25 × 30 | 7500 |
| 00409-1163-01 | J0665 | Pfizer Inc | 25 × 50 | 12500 |
| 00409-1165-01 | J0665 | Pfizer Inc | 25 × 10 | 3750 |
| 00409-1165-02 | J0665 | Pfizer Inc | 25 × 30 | 11250 |
| 50090-4516-00 | J0665 | A-S Medication Solutions | 50 | 500 |
| 51662-1396-01 | J0665 | HF Acquisition Co. LLC, DBA HealthFirst | 50 | 500 |
| 51662-1396-03 | J0665 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 50 | 12500 |
| 51662-1581-03 | J0665 | HF Acquisition Co. LLC, DBA HealthFirst | 25 × 50 | 6250 |
| 52584-0465-57 | J0665 | Henry Schein Inc. | 50 | 250 |
| 52584-0467-57 | J0665 | Henry Schein Inc. | 50 | 500 |
| 55150-0167-10 | J0665 | Eugia US LLC | 25 × 10 | 1250 |
| 55150-0168-30 | J0665 | Eugia US LLC | 25 × 30 | 3750 |
| 55150-0169-10 | J0665 | Eugia US LLC | 25 × 10 | 2500 |
| 55150-0170-30 | J0665 | Eugia US LLC | 25 × 30 | 7500 |
| 55150-0171-10 | J0665 | Eugia US LLC | 25 × 10 | 3750 |
| 55150-0172-30 | J0665 | Eugia US LLC | 25 × 30 | 11250 |
| 55150-0249-50 | J0665 | Eugia US LLC | 25 × 50 | 6250 |
| 55150-0250-50 | J0665 | Eugia US LLC | 25 × 50 | 12500 |
| 70069-0752-25 | J0665 | Somerset Pharma, LLC | 25 × 50 | 6250 |
| 70594-0114-02 | J0665 | Xellia Pharmaceuticals USA, LLC. | 10 × 10 | 500 |
| 70594-0115-01 | J0665 | Xellia Pharmaceuticals USA, LLC. | 30 | 150 |
| 70594-0116-01 | J0665 | Xellia Pharmaceuticals USA, LLC. | 50 | 250 |
| 70594-0117-02 | J0665 | Xellia Pharmaceuticals USA, LLC. | 10 × 10 | 1000 |
| 70594-0118-01 | J0665 | Xellia Pharmaceuticals USA, LLC. | 30 | 300 |
| 70594-0119-01 | J0665 | Xellia Pharmaceuticals USA, LLC. | 50 | 500 |
| 70594-0120-02 | J0665 | Xellia Pharmaceuticals USA, LLC. | 10 × 10 | 1500 |
| 70594-0121-01 | J0665 | Xellia Pharmaceuticals USA, LLC. | 30 | 450 |
| 71288-0721-11 | J0665 | Meitheal Pharmaceuticals Inc. | 10 | 50 |
| 71288-0722-32 | J0665 | Meitheal Pharmaceuticals Inc. | 30 | 150 |
| 71288-0723-52 | J0665 | Meitheal Pharmaceuticals Inc. | 50 | 250 |
| 71288-0724-11 | J0665 | Meitheal Pharmaceuticals Inc. | 10 | 100 |
| 71288-0725-32 | J0665 | Meitheal Pharmaceuticals Inc. | 30 | 300 |
| 71288-0726-52 | J0665 | Meitheal Pharmaceuticals Inc. | 50 | 500 |
| 71288-0727-11 | J0665 | Meitheal Pharmaceuticals Inc. | 10 | 150 |
| 71288-0728-32 | J0665 | Meitheal Pharmaceuticals Inc. | 30 | 450 |
| 71351-0022-10 | J0665 | Brookfield Pharmaceuticals, LLC | 10 × 2 | 300 |
| 72266-0263-10 | J0665 | Fosun Pharma Usa Inc. | 10 × 10 | 500 |
| 72266-0264-10 | J0665 | Fosun Pharma Usa Inc. | 10 × 10 | 1000 |
| 72603-0279-25 | J0665 | Northstar RxLLC | 25 × 50 | 6250 |
| 72603-0287-25 | J0665 | Northstar RxLLC | 25 × 50 | 12500 |
| 72603-0327-25 | J0665 | Northstar RxLLC | 25 × 10 | 1250 |
| 72603-0506-10 | J0665 | Northstar RxLLC | 10 × 10 | 1000 |
| 72603-0506-25 | J0665 | Northstar RxLLC | 25 × 10 | 2500 |
| 72603-0700-10 | J0665 | Northstar RxLLC | 10 × 10 | 1500 |
| 72603-0700-25 | J0665 | Northstar RxLLC | 25 × 10 | 3750 |
| 72603-0800-25 | J0665 | Northstar RxLLC | 25 × 30 | 11250 |
Bupivacaine HCl: common questions
- What is the J-code for Bupivacaine HCl?
- Bupivacaine HCl is billed under HCPCS J0665 — Injection, bupivicaine, not otherwise specified, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 61 Bupivacaine HCl NDCs under this code.
- How many J0665 billing units are in a package of Bupivacaine HCl?
- CMS lists 50 to 12,500 billing units per package, depending on the NDC, where one unit is 0.5 mg. Units to report are based on the dose given, not the package.
- Is J0665 a CPT code?
- No. J0665 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.